{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T21:33:45Z","timestamp":1784842425147,"version":"3.55.0"},"reference-count":13,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2021,12,5]],"date-time":"2021-12-05T00:00:00Z","timestamp":1638662400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI158013"],"award-info":[{"award-number":["R01AI158013"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["P30AI027763"],"award-info":[{"award-number":["P30AI027763"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R25154589"],"award-info":[{"award-number":["R25154589"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R0152119"],"award-info":[{"award-number":["R0152119"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R03AI152773"],"award-info":[{"award-number":["R03AI152773"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R0143340"],"award-info":[{"award-number":["R0143340"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R13AI102630"],"award-info":[{"award-number":["R13AI102630"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI098472"],"award-info":[{"award-number":["R01AI098472"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UMAI164560"],"award-info":[{"award-number":["UMAI164560"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01AI131296"],"award-info":[{"award-number":["U01AI131296"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AI152932"],"award-info":[{"award-number":["R01 AI152932"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01141003"],"award-info":[{"award-number":["R01141003"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI143357"],"award-info":[{"award-number":["R01AI143357"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K23AI157875"],"award-info":[{"award-number":["K23AI157875"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["R24MH094274"],"award-info":[{"award-number":["R24MH094274"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["K23MH122286"],"award-info":[{"award-number":["K23MH122286"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,8,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mRNA vaccination, people living with human immunodeficiency virus (HIV, PLWH) had lower surrogate virus neutralization test response (P\u00a0=\u00a0.03) and a trend toward lower immunoglobulin G (IgG) response (P\u00a0=\u00a0.08), particularly among those with lower CD4+ T-cell counts and who received the BNT162b2 vaccine. Study of the impact of supplemental vaccine doses among PLWH is needed.<\/jats:p>","DOI":"10.1093\/cid\/ciab1009","type":"journal-article","created":{"date-parts":[[2021,12,3]],"date-time":"2021-12-03T20:11:59Z","timestamp":1638562319000},"page":"e916-e919","source":"Crossref","is-referenced-by-count":44,"title":["Differences in Post-mRNA Vaccination Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Immunoglobulin G (IgG) Concentrations and Surrogate Virus Neutralization Test Response by Human Immunodeficiency Virus (HIV) Status and Type of Vaccine: A Matched Case-Control Observational Study"],"prefix":"10.1093","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6368-8664","authenticated-orcid":false,"given":"Matthew A","family":"Spinelli","sequence":"first","affiliation":[{"name":"Division of HIV, ID, and Global Medicine, University of California , San Francisco, San Francisco, California , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J","family":"Peluso","sequence":"additional","affiliation":[{"name":"Division of HIV, ID, and Global Medicine, University of California , San Francisco, San Francisco, California , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kara L","family":"Lynch","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, University of California , San Francisco, San Francisco, California , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassandra","family":"Yun","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, University of California , San Francisco, San Francisco, California , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David V","family":"Glidden","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, University of California , San Francisco, San Francisco, California , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy J","family":"Henrich","sequence":"additional","affiliation":[{"name":"Division of HIV, ID, and Global Medicine, University of California , San Francisco, San Francisco, California , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven G","family":"Deeks","sequence":"additional","affiliation":[{"name":"Division of HIV, ID, and Global Medicine, University of California , San Francisco, San Francisco, California , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Gandhi","sequence":"additional","affiliation":[{"name":"Division of HIV, ID, and Global Medicine, University of California , San Francisco, San Francisco, California , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,12,5]]},"reference":[{"key":"2022082503030602900_CIT0001","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/COH.0000000000000659","article-title":"The interplay between HIV and COVID-19: summary of the data and responses to date","volume":"16","author":"Brown","year":"2021","journal-title":"Curr Opin HIV AIDS"},{"key":"2022082503030602900_CIT0002","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1056\/NEJMc2108861","article-title":"Three doses of an mRNA Covid-19 vaccine in solid-organ transplant recipients","volume":"385","author":"Kamar","year":"2021","journal-title":"N Engl J Med"},{"key":"2022082503030602900_CIT0003","doi-asserted-by":"crossref","first-page":"e0019321","DOI":"10.1128\/JCM.00193-21","article-title":"A SARS-CoV-2 label-free surrogate virus neutralization test and a longitudinal study of antibody characteristics in COVID-19 patients","volume":"59","author":"Luo","year":"2021","journal-title":"J Clin Microbiol"},{"key":"2022082503030602900_CIT0004","doi-asserted-by":"crossref","first-page":"e334","DOI":"10.1016\/S2352-3018(21)00072-2","article-title":"SARS-CoV-2 seroprevalence, and IgG concentration and pseudovirus neutralising antibody titres after infection, compared by HIV status: a matched case-control observational study","volume":"8","author":"Spinelli","year":"2021","journal-title":"Lancet HIV"},{"key":"2022082503030602900_CIT0005","doi-asserted-by":"crossref","first-page":"e0005219","DOI":"10.1371\/journal.pntd.0005219","article-title":"CD4\/CD8 ratio and KT ratio predict yellow fever vaccine immunogenicity in HIV-infected patients","volume":"10","author":"Avelino-Silva","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"2022082503030602900_CIT0006","doi-asserted-by":"crossref","first-page":"e79816","DOI":"10.1371\/journal.pone.0079816","article-title":"Impaired antibody response to influenza vaccine in HIV-infected and uninfected aging women is associated with immune activation and inflammation","volume":"8","author":"Parmigiani","year":"2013","journal-title":"PLoS One"},{"key":"2022082503030602900_CIT0007","doi-asserted-by":"crossref","first-page":"e474","DOI":"10.1016\/S2352-3018(21)00103-X","article-title":"Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2\/3 clinical trial","volume":"8","author":"Frater","year":"2021","journal-title":"Lancet HIV"},{"key":"2022082503030602900_CIT0008","doi-asserted-by":"crossref","first-page":"e568","DOI":"10.1016\/S2352-3018(21)00157-0","article-title":"Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in people living with and without HIV in South Africa: an interim analysis of a randomised, double-blind, placebo-controlled, phase 1B\/2A trial","volume":"8","author":"Madhi","year":"2021","journal-title":"Lancet HIV"},{"key":"2022082503030602900_CIT0009","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/j.cmi.2021.07.031","article-title":"Immunogenicity and safety of the BNT162b2 mRNA Covid-19 vaccine in people living with HIV-1","volume":"27","author":"Levy","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"2022082503030602900_CIT0010","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/infdis\/jiu115","article-title":"The kynurenine pathway of tryptophan catabolism, CD4+ T-cell recovery, and mortality among HIV-infected Ugandans initiating antiretroviral therapy","volume":"210","author":"Byakwaga","year":"2014","journal-title":"J Infect. Dis"},{"key":"2022082503030602900_CIT0011","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1172\/JCI97377","article-title":"Lymphoid tissue fibrosis is associated with impaired vaccine responses","volume":"128","author":"Kityo","year":"2018","journal-title":"J Clin Invest"},{"key":"2022082503030602900_CIT0012","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1056\/NEJMoa2024671","article-title":"Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in nonhuman primates","volume":"383","author":"Corbett","year":"2020","journal-title":"N Engl J Med"},{"key":"2022082503030602900_CIT0013","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1056\/NEJMoa2110345","article-title":"Six month safety and efficacy of the BNT162b2 mRNA COVID-19 Vaccine","volume":"385","author":"Thomas","year":"2021","journal-title":"N Engl J Med"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/75\/1\/e916\/45513994\/ciab1009.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/75\/1\/e916\/45513994\/ciab1009.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T03:05:43Z","timestamp":1661396743000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/75\/1\/e916\/6453392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,5]]},"references-count":13,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12,5]]},"published-print":{"date-parts":[[2022,8,24]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciab1009","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,7,1]]},"published":{"date-parts":[[2021,12,5]]}}}